JPRN-UMIN000015381已完成未知
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitus - Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitus
Kanagawa PTCA Conference0 个研究点目标入组 50 人开始时间: 2014年10月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients who are suspected as having significant stenosis evaluated by CCTA and require to receive percutaneous coronary intervention (PCI) (2)Patients with acute coronary syndrome within 30 days (3)Patients with the past history of PCI(4)Patients with post coronary artery bypass grafting (CABG) (5)Patients with complex congenital heart disease (6)Patients with body mass index >35kg/m2 (7)Patients with the past history of heart failure (8)Patients with the past history of ketoacidosis or diabetic coma (9)Patients with hepatic disorder or with AST (GOT) or ALT (GPT) greater than 2 times of the upper limits of normal (10)Patients with renal dysfunction (estimated glomerular filtration rate 30 ml/min/1.73m2 or lower) (11)Patients with severe infection, pre or post operation, or severe trauma (12)Patients with a history of hypersensitivity to any of the components of alogliptin (13)Pregnant women, women suspected of being pregnant, or lactating women (14)Patients ineligible for the study determined by physicians
研究者
相似试验
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
招募中
不适用
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysisType 2 diabetic patients on hemodialysisJPRN-UMIN000006024Chibune general hospital5
进行中（未招募）
1 期
Effects of linagliptin on left ventricular myocardial DYsfunction in patients with type 2 DiAbetes mellitus.Type 2 Diabetes mellitusMedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersEUCTR2014-004683-38-ITFondazione per il Tuo cuore onlus-ANMCO186
招募中
不适用
Investigation of the impact of DPP-4 inhibition on serum brain natriuretic peptide level of diabetic patients with congestive heart failure.JPRN-UMIN000015685Mitsui Memorial Hospital50